Table 1 Characteristics of the benefit schemes State Guaranteed Benefit Programme and Additional Drug Package in Kyrgyzstan
Benefit programme | SGBP | ADP |
|---|---|---|
Full name | State Guaranteed Benefit Programme | Additional Drug Package |
Year of introduction | 2001, first on a pilot basis, then rolled out nationwide | 2001, first on a pilot basis, then rolled out nationwide |
Objectives | To improve access to defined health care services for vulnerable population groups and to increase the efficiency of health services | To improve affordability and accessibility of medicines by limiting the financial burden on households and to encourage more rational prescribing and use of medicines |
Services covered | Primary, secondary and tertiary care; medicines for few defined diseases (see below) | Only medicines |
Sectors covered | Outpatient and inpatient sectors | Outpatient sector |
Eligibility | Any person, regardless of insurance status, with a defined eligible disease | Only patients insured by the Mandatory Health Insurance Fund (MHIF): prescriptions to be filled in community pharmacies in a contractual relationship with the MHIF |
Medicines included | Coverage of medicines for defined diseases, including bronchial asthma, cancer in the terminal phase, mental disorders (schizophrenia and affective disorders) and epilepsy | Focus is on medicines for non-communicable diseases:58 international non-proprietary names (INN) of medicines and two medical devices in 2015 |
Co-payment | 0% in principle, but some co-payments in reality as prices are not regulated | 50% of the calculated tariff, but as prices are not regulated, practice rarely corresponds to 50% of the price paid by patients |